Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H19NO4 |
Molecular Weight | 301.3371 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@]3(O)CCC4=O)=CC=C5O
InChI
InChIKey=UQCNKQCJZOAFTQ-ISWURRPUSA-N
InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1
Molecular Formula | C17H19NO4 |
Molecular Weight | 301.3371 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:16:42 UTC 2023
by
admin
on
Fri Dec 15 16:16:42 UTC 2023
|
Record UNII |
9VXA968E0C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175690
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
||
|
LIVERTOX |
NBK548775
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
||
|
NDF-RT |
N0000175684
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
||
|
NCI_THESAURUS |
C1506
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
||
|
FDA ORPHAN DRUG |
6185
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
||
|
DEA NO. |
9652
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8060
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
7814
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | RxNorm | ||
|
C29314
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
5284604
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
19045
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
SUB09569MIG
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
9VXA968E0C
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
m8338
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | Merck Index | ||
|
OXYMORPHONE
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
DB01192
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
200-959-7
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
CHEMBL963
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
DTXSID5023409
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
9VXA968E0C
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
2034
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
Oxymorphone
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
100000083286
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
937
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
D010111
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
1488000
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
7094
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY | |||
|
76-41-5
Created by
admin on Fri Dec 15 16:16:42 UTC 2023 , Edited by admin on Fri Dec 15 16:16:42 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
6-OH-oxymorphone has been shown in animal studies to have analgesic bioactivity
MAJOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
PARENT -> METABOLITE ACTIVE |
Highly variable 40 fold higher potency than Oxycodone
MINOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
6-OH-oxymorphone has been shown in animal studies to have analgesic bioactivity.
MAJOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||